Skip navigation

Industry Best Practices and Strategies for Managing and Enhancing Ethics and Integrity Programs

June 11-12, 2019
  • Toronto, Canada

CBI’s 3rd Annual Pharmaceutical Compliance Congress Canada convenes top Canadian compliance practitioners and leading experts to discuss effective strategies to achieve organization-wide compliance, from the compliance and legal teams to the oversight of the promotional marketing and sales teams. Join your Canadian colleagues for robust conversations on the top issues facing industry today.

GATHER THE LATEST INSIGHTS & CURRENT TRENDS

  • Achieve commercial compliance readiness — Redesign operations to support and accommodate transparency reporting
  • Educate HCPs compliantly through OLAs — Understand the key differentiators between OLAs and promotional activities
  • Identify common practices for executing on patient support programs and identify key risk areas
  • Ensure Fair Market Value to manage risk — Examine FMV methodologies, review common risk areas and best practices
  • Utilize data driven monitoring to manage third-party risk and assess vendor effectiveness
  • Evaluate industry partnerships for physician education —
    Examine potential areas where codes for physicians and manufacturers may not be aligned
  • Engage and collaborate with key internal stakeholders to manage compliance risk and progress the compliance function into a strategic advisory role

CAN’T MISS FEATURES:

  • Conference Kick-off Benchmarking Session —
    Participate in a live-polling session and identify where your compliance program aligns with industry
  • Dynamic Q&A sessions with Health Canada and PAAB
  • Deep Dive Workshops on Advanced Compliance Monitoring Activities and Critical Steps for Ensuring Readiness for Transparency Reporting
  • 6 Interactive Panel Sessions addressing key compliance risk areas, non-pharma industry perspectives on compliance trends as well as innovative approaches for managing conflict of interest
  • Table Talk Luncheon Roundtables where you drive the discussions
  • Build your relationships with compliance professionals

This education activity has been submitted to the Compliance Certification Board (CCB)® and is currently pending their review for approval of CCB CEUs.

PREVIOUS ATTENDEE ACCLAIM:

Excellent conference. Superb content and speakers. Great discussion with colleagues...2 days well spent.

Compliance Counsel, Novo Nordisk Canada

The conference is on-point for anyone in
the compliance world in Canada.

Medical Compliance, Janssen

It was great learning what worked and didn’t work for other companies in terms of raising the awareness of compliance with my own respective pharmaceutical company.

Compliance Specialist, Sanofi-Pasteur

Excellent conference!
Worth taking two days from work.

Chief Compliance Officer, Boehringer Ingelheim

It was great learning what worked and didn’t work for other companies in terms of raising the awareness of compliance with my own respective pharmaceutical company.

Compliance Specialist, Sanofi-Pasteur

3rd Annual Pharmaceutical Compliance Congress Canada

Industry Best Practices and Strategies for Managing and Enhancing Ethics and Integrity Programs

CBI’s 3rd Annual Pharmaceutical Compliance Congress Canada convenes top Canadian compliance practitioners and leading experts to discuss effective strategies to achieve organization-wide compliance, from the compliance and legal teams to the oversight of the promotional marketing and sales teams. Join your Canadian colleagues for robust conversations on the top issues facing industry today.

GATHER THE LATEST INSIGHTS & CURRENT TRENDS

  • Achieve commercial compliance readiness — Redesign operations to support and accommodate transparency reporting
  • Educate HCPs compliantly through OLAs — Understand the key differentiators between OLAs and promotional activities
  • Identify common practices for executing on patient support programs and identify key risk areas
  • Ensure Fair Market Value to manage risk — Examine FMV methodologies, review common risk areas and best practices
  • Utilize data driven monitoring to manage third-party risk and assess vendor effectiveness
  • Evaluate industry partnerships for physician education —
    Examine potential areas where codes for physicians and manufacturers may not be aligned
  • Engage and collaborate with key internal stakeholders to manage compliance risk and progress the compliance function into a strategic advisory role

CAN’T MISS FEATURES:

  • Conference Kick-off Benchmarking Session —
    Participate in a live-polling session and identify where your compliance program aligns with industry
  • Dynamic Q&A sessions with Health Canada and PAAB
  • Deep Dive Workshops on Advanced Compliance Monitoring Activities and Critical Steps for Ensuring Readiness for Transparency Reporting
  • 6 Interactive Panel Sessions addressing key compliance risk areas, non-pharma industry perspectives on compliance trends as well as innovative approaches for managing conflict of interest
  • Table Talk Luncheon Roundtables where you drive the discussions
  • Build your relationships with compliance professionals

This education activity has been submitted to the Compliance Certification Board (CCB)® and is currently pending their review for approval of CCB CEUs.

PREVIOUS ATTENDEE ACCLAIM:

Excellent conference. Superb content and speakers. Great discussion with colleagues...2 days well spent.

Compliance Counsel, Novo Nordisk Canada

The conference is on-point for anyone in
the compliance world in Canada.

Medical Compliance, Janssen

It was great learning what worked and didn’t work for other companies in terms of raising the awareness of compliance with my own respective pharmaceutical company.

Compliance Specialist, Sanofi-Pasteur

Excellent conference!
Worth taking two days from work.

Chief Compliance Officer, Boehringer Ingelheim

It was great learning what worked and didn’t work for other companies in terms of raising the awareness of compliance with my own respective pharmaceutical company.

Compliance Specialist, Sanofi-Pasteur